Residency Essentials: Hepatocellular Carcinoma 2

Hepatocellular carcinoma 2 (advanced stage therapies, trans arterial therapies and systemic therapies)

Hepatocellular carcinoma 2 is an introductory course for intermediate-advanced stage therapies, transarterial therapies, and systemic therapies for HCC. The fundamental concepts introduced in this course will provide an overview of available therapies, patient selection/eligibility, technical details, and assessment of treatment response. Future courses will build on these concepts. 

Expected completion time: 4 hours 

Learning Objectives

  • Describe patient selection for transarterial and systemic therapies in intermediate to advanced HCC.
  • Learn basic technical approaches for transarterial therapies.
  • Understand tumor response assessment criteria.
  • Review hepatic angiography.
  • Be familiar with the role for medical and radiation oncology in advanced HCC.
Course summary
Course opens: 
07/01/2025
Course expires: 
12/31/2030
Cost:
$0.00
Part of: 
Residency Essentials Clinical Topic: Oncology

Course Developers: 

  • Andrew C Gordon, MD, PhD- Northwestern University
  • Nicholas S Xiao Degree, MD- Northwestern University 
  • Kent T Sato, MD, FSIR- Northwestern University 

Price

Cost:
$0.00
Please login or register to take this course.

Click the green "Take Course" button to get started.

Required Hardware/software

Google Chrome is the preferred web browser.